Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report.

Fox, Henrik; Gummert, Jan F; Sommer, Philipp; Knabbe, Cornelius; Sohns, Christian

Fox, Henrik; Gummert, Jan F; Sommer, Philipp; Knabbe, Cornelius; Sohns, Christian.

Fox H; Clinic for Thoracic and Cardiovascular Surgery, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Gummert JF; Heart Failure Department, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Sommer P; Clinic for Thoracic and Cardiovascular Surgery, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Knabbe C; Heart Failure Department, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Sohns C; Heart Failure Department, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.

Cardiol J ; 29(1): 157-159, 2022.

Article in English | MEDLINE | ID: covidwho-1463972

Subject(s)

COVID-19; Shock, Cardiogenic; COVID-19/complications; Cardiotonic Agents/pharmacology; Cardiotonic Agents/therapeutic use; Convalescence; Humans; Hydrazones; SARS-CoV-2; Shock, Cardiogenic/diagnosis; Shock, Cardiogenic/drug therapy; Shock, Cardiogenic/etiology; Simendan/pharmacology; Simendan/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Shock, Cardiogenic / COVID-19 Type of study: Case report / Diagnostic study / Experimental Studies Topics: Long Covid Limits: Humans Language: English Journal: Cardiol J Year: 2022 Document Type: Article Affiliation country: CJ.a2021.0119

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google